Recent studies have shown that decreased expression of PERK in human breast cancer cells is associated with increased global phosphorylation of ATM and increased phosphorylation of its downstream effector CHK2, a cell cycle checkpoint kinase associated with DNA damage repair [82, 129] (Fig. 2). This evidence concerns the gene EIF2AK3 and breast carcinoma.